Leadership Team
Leadership Team
OssiFi has a management team with deep expertise in discovering, developing, and commercializing novel therapeutics.
Debra L. Ellies Ph.D., CEO
Reid Leonard, PhD, Corporate Development
Steve Peckham, Ph.D., Product Development
F. Scott Kimball, Ph.D., Head of Discovery
Randal Pratt, Counsel
Debra L. Ellies Ph.D., CEO
Frank Loeffler, Chairman
Kelly Drouillard
Matt Siegel
-
![]()
Corporate Development
ButtonPrivately held company. Since its inception, it has been capitalized using convertible notes, non-dilutive grants, and equity.
-
![]()
Professionals
ButtonOssiFi is developing best in class sclerostin small molecule inhibitors to take advantage of new opportunities to develop safer, more effective bone building therapies.
-
![]()
Distribution List
ButtonSign up to keep updated on OssiFi news.
-
![]()
Careers
ButtonOssiFi takes pride in finding the perfect match for our team. We have created a culture that resonates our innovation.
ABOUT US
OssiFi Therapeutics is an innovative bone-biology company operating at the intersection of therapeutics and medical devices to address significant unmet needs in neurogenic low back pain, fracture repair, and fracture prevention.